Cargando…
Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma
Multiple myeloma (MM) is the second most prevalent hematologic malignancy. In the past few years, the survival of MM patients has increased due to the emergence of novel drugs and combination therapies. Nevertheless, one of the significant obstacles in treating most MM patients is drug resistance, e...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094562/ https://www.ncbi.nlm.nih.gov/pubmed/37046991 http://dx.doi.org/10.3390/ijms24076019 |